CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies — StellaEarly Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(1 site)
China
The First Hospital of Zhejiang Medical Colleage Zhejiang University, Hangzhou, Zhejiang Age range
18 Years – 70 Years
Last updated October 2020